|
|
 | |
Bipolar Research Studies
Clinical trial of riluzole in pediatric bipolar disorder
Date: Oct. 6, 2011
This study is testing the effectiveness of riluzole versus placebo for decreasing anxiety in children with pediatric bipolar disorder (BP). Children and youth with bipolar disorder display episodic elevated mood and associated symptoms of decreased need for sleep, increased goal-directed behavior, and increased self-esteem/grandiosity.
Children ages 9 to 17 with BP may be eligible to participate in this 12- to 15-week inpatient or outpatient study. This study has four phases. During Phase I, participants are gradually withdrawn from all current psychotropic medications. Phase II is a one-week medication-free period. During Phase III, which lasts two weeks, participants are randomly assigned to also receive either riluzole or placebo (a “sugar pill”). Phase IV lasts for 6 weeks. During this time, participants continue riluzole or placebo.
At the end of the study, those who received placebo have the opportunity to receive riluzole.
All procedures and medications associated with the research are provided at no cost to participants, and assistance with transportation and lodging expenses is available. Schooling will be provided while on the inpatient unit or in day treatment.
To find out if you qualify or for more information, please call (301) 496-8381 or email us at bipolarkids@mail.nih.gov.
National Institute of Mental Health
National Institutes of Health
Department of Health & Human Services
[The principal researcher is Ellen Leibenluft, M.D., Chief, Unit on Affective Disorders, NIMH Pediatrics and Developmental Neuropsychiatry Branch]
Do you have a parent, child or sibling with schizophrenia, schizoaffective disorder, or bipolar disorder?
Age: 18+
Location: By telephone, web or email.
If you answered "yes", we would love to hear from you! We are UBC researchers who have developed a questionnaire to help measure internalized stigma in first-degree relatives of people with a severe mental illness.
What is the purpose of the research?
Stigma affects individuals with a mental illness and their family members. The purpose of this study is to validate a questionnaire that we have recently developed to measure internalized stigma in first-degree family members (parents, brothers, sisters, and children) of people with schizophrenia, bipolar disorder, or schizoaffective disorder. The questionnaire will be used to gather information about how family members of people with mental illness experience stigma, which can also be helpful in evaluating the well being of family members. Later on, the questionnaire will also be used in the development and evaluation of strategies to reduce individuals’ internalized stigma.
Who can participate?
Parents, siblings, and children of people with schizophrenia, schizoaffective disorder, or bipolar disorder. We are looking for both men and women to participate in this study.
What is involved in participating?
If you participate in this study you will be asked to complete questionnaires at two time points that are one month apart. The questionnaires include the new stigma questionnaire as well as 7 other questionnaires (that ask about things like self-esteem and mood).
You do not have to travel to participate in this study; you can participate entirely from home by telephone and mail/email.
Each time point should take approximately 30 – 45 minutes of your time to complete.
How do I participate?
If you are interested in participating, please contact the Research Coordinator (Emily) at: 604-875-2000 x4732 or by email at mental.illness@ubc.ca
Posted: August 10, 2010
Survey of parents who have been diagnosed with bipolar disorder
Researchers at the National Human Genome Research Institute of the National Institutes of Health are seeking parents who have been diagnosed with bipolar disorder to participate in an online survey. The survey will take about 45 minutes to complete. In the survey, we ask questions about participants’ thoughts about their bipolar disorder and how they deal with bipolar disorder. We also ask about participants’ thoughts about the chance that their children might get a mood disorder someday, and how they feel about that chance. The survey is completely anonymous.
To participate, you must:
- Have a diagnosis of bipolar disorder
- Be 18 years or older
- Be a biological parent of a child who is younger than 30 years old
- Be willing to participate in the survey
Your child cannot have been diagnosed with a mood disorder or other serious psychiatric disorder. Your child cannot have been adopted. You must be (or must have been) involved in taking care of your child. Your child must be younger than 30 years of age.
Taking the survey could make you uncomfortable. If you become uncomfortable, you can stop taking the survey. There are no benefits to participating.
If you would like to participate, please go to http://www.surveymonkey.com/s/parents_with_bipolar to take the survey.
If you have questions about the study, please contact the study co-investigator, Holly Peay, at hpeay@mail.nih.gov or 301- 496-3979.
Posted Jan 7, 2010
Schizophrenia and Bipolar Disorder Family Genetic Research Study
Location:
Age: 15-65
The
You may be eligible to participate in the study if you meet these conditions:
- Age between 15-65 years
- Diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder (with psychosis)
- Have at least one biological first-degree relative, i.e., a sister, brother, mother or father willing to participate. The relative does not need to be diagnosed with a psychiatric disorder but it is ok if they are
- No serious medical, neuro-opthalmological or neurological illness (e.g., cancer, seizure disorders, encephalopathy)
- No current substance abuse (within past 3 months) or past history of substance dependence (within 6 months or extensive history)
- No ferromagnetic objects lodged in the body
Participation involves:
- Clinical interviews to evaluate diagnosis and gather other personal information
- Neuropsychological Tests to examine thinking abilities such as attention and memory
- Electroencephalography (EEG)/Sensory Gating tests to measure brain activity in response to sounds
- Eyetracking tests to measure eye movements and visual attention
- MRI to measure brain structures and function
- Blood sample for DNA (genetic) studies
- Urine sample to screen for drugs and pregnancy
The total amount of time it takes to complete the study is approximately 14-16 hours. Transportation can be provided if needed. All participants will be compensated for their time.
For more details, call our research coordinator, Jennifer Jones, at 410-402-6823
Posted: April 15, 2009
Child Bipolar Disorder Study
Age: 10-17
Location: Ohio
Is your child or teen being treated for bipolar I disorder and still experiencing symptoms?
Your child or teen may qualify to participate in a clinical research study in your area evaluating an investigational medication as a potential add-on treatment for bipolar I disorder in children and teens ages 10-17. Children and teens enrolled in this study may continue on their current prescribed medications. Each participant will receive comprehensive, study-related evaluations and investigational study medication at no cost. Compensation for time and travel may also be provided to those who qualify. Please call The Ohio State University, Department of Psychiatry Clinical Research Office at 614-293-7109 or e-mail clinicaltrials@osumc.edu to learn more.
Posted: February 17, 2009
|
|
|
| |
Join NAMI today!
When you become a member of NAMI, you become part of America's largest grassroots organization dedicated to improving the lives of persons living with serious mental illness. And now you can join online.
Copyright © 1996 - 2011 NAMI. All Rights Reserved.